Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026)

Verano Holdings (VRNO) reported Depreciation & Amortization (CF) of $29.2 million for Q1 2026, down 8.19% year-over-year from $31.8 million in Q1 2025, and little changed quarter-over-quarter from $29.3 million in Q4 2025.

Verano Holdings (VRNO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $29.2 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $29.2 million, down 8.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $121.6 million (down 10.56% YoY), and the FY2025 annual result was $124.2 million, down 11.1% from the prior year.
  • Depreciation & Amortization (CF) steadied at $29.2 million in Q1 2026 per VRNO's latest filing, from $29.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $36.9 million in Q3 2024 and troughed at $29.2 million in Q1 2026.
  • A 5-year average of $33.9 million and a median of $35.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 46.15% in 2022, then slipped 14.39% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $35.2 million in 2022, then gained by 1.19% to $35.6 million in 2023, then fell by 11.41% to $31.5 million in 2024, then dropped by 6.97% to $29.3 million in 2025, then fell by 0.44% to $29.2 million in 2026.
  • Business Quant data shows VRNO's Depreciation & Amortization (CF) at $29.2 million in Q1 2026, $29.3 million in Q4 2025, and $31.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Verano Holdings - - 98.98 Mn 29.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.19 Mn
Mar 31, 2026 29.19 Mn
Dec 31, 2025 29.32 Mn
Dec 31, 2025 29.32 Mn
Sep 30, 2025 31.56 Mn
Sep 30, 2025 31.56 Mn
Jun 30, 2025 31.49 Mn
Jun 30, 2025 31.49 Mn
Mar 31, 2025 31.79 Mn
Mar 31, 2025 31.79 Mn
Dec 31, 2024 31.51 Mn
Dec 31, 2024 31.51 Mn
Sep 30, 2024 36.87 Mn
Sep 30, 2024 36.87 Mn
Jun 30, 2024 35.73 Mn
Jun 30, 2024 35.73 Mn
Mar 31, 2024 35.55 Mn
Mar 31, 2024 35.55 Mn
Dec 31, 2023 35.57 Mn
Dec 31, 2023 35.57 Mn